Completed Cells, Biochemistry & Physiology Computing & AI

Lighting the Way to a Healthy Nation - Optical 'X-rays' for Walk Through Diagnosis & Therapy

In plain English

AI plain-English summary

Walking through an archway could soon generate a detailed 3D scan of your body using invisible light, without any radiation or dyes. This research addresses a looming healthcare crisis. By 2050, over 2 billion people will be over 60, and hip fractures worldwide are projected to rise from 1.7 million in 1990 to 6.3 million. Meanwhile, half the UK population is predicted to be obese, and the lifetime cancer risk will climb to 8 in 10. Current diagnostic tools—X-rays, biopsies, contrast agents—are invasive, expensive, or use ionising radiation. The team aims to replace them with harmless, invisible laser light that penetrates tissue, combined with AI to reconstruct high-resolution 3D images. If successful, this technology could transform medical diagnostics. Patients would walk through a scanner during a routine visit, catching osteoarthritis or early-stage tumours before symptoms appear. The same light could also treat disease: focusing micron-precision beams to destroy tumours, activate drugs in a 3D pattern, or even drive fat cell metabolism. For the NHS, this means earlier intervention, lower costs, and fewer invasive procedures. The project is ambitious but grounded in existing optical physics and detector chemistry—a practical vision for 2050.

View original technical description
Imagine a world where walking through a revolving door or archway allows "invisible light" (light outside our normal visual range) to generate detailed 3D images of any patient with high resolution! This is the global vision and targeted ambition of this 2050 proposal. This will allow us to target very early detection of disease using light (referred to as a non-ionising radiation technology) in association with fast computational methods and artificial intelligence (AI) to reconstruct images. This will be transformative, is a practical reality, and in addition potentially offers unique treatment options for the healthcare needs of 2050. These goals will be achieved by simultaneous interdisciplinary advances: - Harnessing of world-leading optical physics - with lasers that work at wavelengths of light that are invisible to the naked eye - akin to radio waves but with very different frequencies. - Rethinking of existing detector technology and development of layers of new chemistries and sensor materials to allow them to function at these "invisible colours" - Development of novel image restoration tools and new computational optics and imaging that will allow us to access information at depth that was previously hidden without any injection of dyes or causing inconvenience. - Validation of the technology on diseases that have huge impacts on quality of life and huge NHS costs, for example osteoarthritis and cancer. Why is this needed? (i). Bone disease: By 2050 there will be over 2 billion people aged over 60. This is wonderful news for us all, but will present a variety of healthcare challenges. For example it is predicted that the numbers of hip fractures worldwide will increase from 1.7 million in 1990 to 6.3 million in 2050. In addition, musculoskeletal conditions are worsened by the rising problem of obesity - that affects old and young alike with half the UK population predicted to be obese by 2050. Our technology will impact on these statistics. Detecting disease early and affordably and non-invasively will allow life-style changes to be made by patients (before it is too late) - leading to positive effects on quality of life and broad impact in relation to the NHS. (ii). Cancer: In the UK 1 in 2 of those born after 1960 will develop cancer with a 20% chance of dying from that cancer within 5 years. In 2050, as longevity has increased, the chances of someone getting cancer in their lifetime will be 8 in 10. Being able to influence these statistics will have dramatic impacts. Our vision is that non-invasive externally applied illumination sources - with micron precision - will be able to illuminate a tumour in a three-dimensional sense and destroy it. Driving patient health: Now think of the impact of what else the deeply penetrating and focused light might be able to do? Interacting with tissues selectively in a three-dimensional manner - could we hit activate drugs in a localised 3D pattern? Will we be able to drive fat cell metabolism? The possibilities are tremendous and we seek to address these in our research.

View the original record at the funder ↗

Researchers

Ahsan Akram (Co-Investigator)Amanda Wright (Co-Investigator)Andrew Parkes (Co-Investigator)David Richardson (Co-Investigator)Hamish Simpson (Co-Investigator)Lin Xu (Co-Investigator)Mark Bradley (Principal Investigator)Mercedes Torres Torres (Co-Investigator)Michael Somekh (Co-Investigator)Richard Oreffo (Co-Investigator)Robert Henderson (Co-Investigator)Sumeet Mahajan (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Towards disease diagnosis through spectrochemical imaging of tissue architecture.
PREDICTOR - PRE-symptomatic DIagnosis through adaptive optiCal Tomographic sensing Of the Retina
Engineering Precision Medicine for the 21st Century
Seeing Life Through a New Light: Photonics for healthcare and medicine
Next-Generation Sensing For Human In Vivo Pharmacology- Accelerating Drug Development In Inflammatory Diseases

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.